This effect of artemisinin is normally thought to be responsible for NLRP3 inhibitory effects in a transgenic murine (APPswe/PS1dE9) model of Alzheimer’s Disease [152]. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.